They found that epicutaneous sensitization with ovalbumin in mice further challenged with intranasal ovalbumin led to increased expression of IL-22 in serum and lungs, which was associated with enhanced AHR and mixed neutrophilic and eosinophilic airway inflammation. The gene discussed is IL22; the disease is inflammation.